137,274 PACS Group, Inc. $PACS Shares Sold by Royce & Associates LP

Royce & Associates LP decreased its holdings in shares of PACS Group, Inc. (NYSE:PACS – Free Report) by 15.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 775,218 shares of the company’s stock after selling 137,274 shares during the period. Royce & Associates LP’s holdings in PACS Group were worth $32,210,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nisa Investment Advisors LLC increased its stake in shares of PACS Group by 11.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock worth $97,000 after purchasing an additional 230 shares in the last quarter. Financial Management Professionals Inc. raised its holdings in PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after purchasing an additional 235 shares during the period. Smith Group Asset Management LLC lifted its position in PACS Group by 1.3% during the third quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock valued at $1,025,000 after purchasing an additional 320 shares in the last quarter. Jacobsen Capital Management lifted its position in PACS Group by 3.4% during the third quarter. Jacobsen Capital Management now owns 17,837 shares of the company’s stock valued at $741,000 after purchasing an additional 579 shares in the last quarter. Finally, Toth Financial Advisory Corp lifted its position in PACS Group by 87.5% during the third quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock valued at $62,000 after purchasing an additional 700 shares in the last quarter.

PACS Group Price Performance

Shares of PACS stock traded up $0.21 on Friday, hitting $48.21. 464,311 shares of the stock traded hands, compared to its average volume of 924,401. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.80 and a quick ratio of 0.80. PACS Group, Inc. has a 52 week low of $10.31 and a 52 week high of $51.68. The firm has a 50 day simple moving average of $45.25 and a two-hundred day simple moving average of $40.38. The firm has a market cap of $7.65 billion, a price-to-earnings ratio of 27.24, a PEG ratio of 1.56 and a beta of -0.14.

PACS Group (NYSE:PACS – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. As a group, equities research analysts predict that PACS Group, Inc. will post 2.05 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Jason Murray sold 167,434 shares of the stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the completion of the sale, the chief executive officer owned 53,954,101 shares in the company, valued at approximately $2,710,654,034.24. This trade represents a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of PACS Group stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total value of $9,418,813.20. Following the sale, the director directly owned 53,318,884 shares in the company, valued at $2,689,937,697.80. This trade represents a 0.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,781,666 shares of company stock worth $81,840,913 over the last 90 days. Company insiders own 70.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on PACS. Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Oppenheimer raised their price objective on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Weiss Ratings raised PACS Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, November 4th. Zacks Research cut PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Finally, Stephens boosted their price objective on PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a research note on Thursday, November 5th. Seven equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $61.33.

Read Our Latest Report on PACS

PACS Group Company Profile

(Free Report)

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

Featured Articles

Want to see what other hedge funds are holding PACS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PACS Group, Inc. (NYSE:PACS – Free Report).

Institutional Ownership by Quarter for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.